Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has increased the maximum quantity of cannabis imports for medical and scientific purposes to approximately 192.5...

The post Germany increases medical cannabis import limit by 70 tonnes appeared first on StratCann.

Germany's Federal Institute for Drugs and Medical Devices (BfArM) tells B2B trade magazine Kraut Invest that the current demand estimate for cannabis for medical purposes...

The post Germany: No new import permits for dried cannabis in 2025 appeared first on StratCann.

Germany's Federal Institute for Drugs and Medical Devices (BfArM) tells B2B trade magazine Kraut Invest that the current demand estimate for cannabis for medical purposes...

The post Germany: No new import permits for dried cannabis in 2025 appeared first on StratCann.

A German pharmaceutical company specializing in the importation and wholesale of medical cannabis is facing scrutiny following claims that the company is distributing different cannabis...

The post Accusations levelled at German medical cannabis importer with Canadian ties appeared first on StratCann.

High Tide Inc. has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of €26.4 million (C$42.4 million). The acquisition...

The post High Tide closes acquisition of a majority stake in Remexian Pharma GmbH appeared first on StratCann.

A German pharmaceutical company specializing in the importation and wholesale of medical cannabis is facing scrutiny following claims that the company is distributing different cannabis...

The post Accusations levelled at German medical cannabis importer with Canadian ties appeared first on StratCann.